Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 9, 2022

View Archived Issues

New PET ligand allows in vivo pharmacological evaluation of agents targeting mutant HTT expression

New in vitro model represents the 3D architecture, composition and mechanics of connective tissues

DPEP1 antagonist LSALT shows promise in preclinical models of acute kidney injury

Scientists identify role of PDGF-D-PDGFR-beta signaling pathway in survival of human NK cells

Discovery of novel monoclonal antibodies against emerging SARS-CoV-2 variants of concern

Non-muscle-targeted AAV8/DC190-ASM gene therapy for treating limb girdle muscular dystrophy 2B

IFM Due patents hSTING antagonists for cancer

Nanjing Zhengxiang Pharmaceuticals divulges DHODH inhibitors

Korean researchers synthesize PDE5A and HDAC6 dual inhibitors for Alzheimer's

Caregen identifies new antivirals for SARS-CoV-2

Eisai divulges new OX2 receptor agonists for narcolepsy

MDL-001 significantly reduces SARS-CoV-2 viral load in lungs in preclinical study

Immunome's antibody cocktail effective against live versions of SARS-CoV-2 Omicron variant in vitro

Xanadu signs agreements with Yale to support development of intranasal SARS-CoV-2 vaccine booster

SENS-401 shows good local bioavailability in sensorineural hearing loss model

For pain signaling, endocytosis is not the end

New drug combinations with synergistic inhibitory activity against SARS-CoV-2

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...